- Salmonella Outbreak Triggers Recall of Cucumbers in 26 States
- Switch From Animal to Plant Proteins Greatly Boosts Heart Health
- Workers Who Make Kitchen Countertops Face Big Lung Hazards
- When’s Best Time for Your COVID Booster? That May Depend on You
- Cervical Cancer Deaths Fell Dramatically After Advent of HPV Vaccine
- Antibiotics or Surgery: What’s Best for Child Appendicitis?
- Newer Epilepsy Meds Safe During Pregnancy, Won’t Affect Kids’ Neurodevelopment
- CTE Plus Family History of Mental Illness Raises Odds for Aggression
- Over 100,000 U.S. Youth Battle Inflammatory Bowel Disease
- Smoker or Former Smoker? Here Are 4 Key Things You Need to Know
NSAIDS, Steroids for Back Pain: Is Too Much of Them a Bad Thing?
Persistent use of steroids and non-steroidal anti-inflammatory drugs (NSAIDs) like ibuprofen to treat acute lower back pain may actually turn it into a chronic condition, a new study warns.
However, some experts who expressed concerns about the study published in the journal Science Translational Medicine pointed out that it was not a clinical trial, which is the gold standard for medical research, The New York Times reported.
The findings by the team at McGill University in Montreal are based on observations of patients, an analysis of a large patient database and an animal study.
The study results suggest we “need to think further about how to treat our patients,” lead investigator Dr. Luda Diatchenko, a professor who specializes in human pain genetics, told the Times.
Back pain is the most common type of pain, according to the U.S. Centers for Disease Control and Prevention.
The research is “intriguing, but requires further study,” Dr. Steven Atlas, director of primary care practice-based research and quality improvement at Massachusetts General Hospital, told the Times.
That opinion was echoed by Dr. Bruce Vrooman, a pain specialist at Dartmouth Hitchcock Medical Center in New Hampshire. But Vrooman also told the Times that the study was “impressive in its scope” and added that if the findings hold up in a clinical trial, it could “force reconsideration of how we treat acute pain.”
The study represents a “paradigm shift,” Dr. Thomas Buchheit, director of the regenerative pain therapies program at Duke University, told the Times.
“There is this unspoken rule: If it hurts, take an anti-inflammatory, and if it still hurts, put a steroid on it,” he said. But this study shows that “we have to think of healing, and not suppression of inflammation.”
Current guidelines advise people with back pain to begin with exercise, physical therapy, heat or massage, which can be as effective as pain medications but don’t cause the same side effects.
If those approaches don’t work, patients can try NSAIDs like ibuprofen, the guidelines advise. Acetaminophen (best known as Tylenol) is not an anti-inflammatory.
More information
Visit the National Library of Medicine for more on back pain.
Source: HealthDay
Copyright © 2024 HealthDay. All rights reserved.